Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 4, 2025Journal of Saidu Medical College Swat

The COVID-19 Pandemic and the Escalation of Rhino-Orbital-Cerebral Mucormycosis: A Retrospective Review

View Full Paper
Ask AI
Bookmark
Share

Authors

NKNaveed Ullah KhanUFUmar FarooqIIhsanullah

Discussion

Loading...

Member takes

Overview

Retrospective review highlights high mortality in post-COVID-19 patients with mucormycosis, indicating critical need for improved interventions.

Key Points

  • The fatality rate of patients with rhino-orbital-cerebral mucormycosis after COVID-19 infection was 32.3%.
  • Most patients (91.17%) had diabetes, and 88.3% had recent COVID-19 history.
  • Surgical debridement was performed on all patients, with 88.23% using a modified endoscopic approach.
  • Intracranial extension and uncontrolled diabetes significantly increased mortality risks, emphasizing urgent care needs.

Cite This Study

Khan et al. (2025) studied this question.

synapsesocial.com/papers/689a0f86e6551bb0af8d0b9bhttps://doi.org/10.52206/jsmc.2025.15.3.1215
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A comparative study of risk factors of rhino orbital cerebral mucormycosis (ROCM) in COVID-19 patients2025
  2. 2Survival from rhino-orbital-cerebral mucormycosis in SARS-COV-2 positive diabetic patients: Two case reports2024 · 2 citations
  3. 3Scenario of mucormycosis in COVID-19 pandemic era from a tertiary care center in West Bengal2026
  4. 4International Session 55　　Olfaction2026
  5. 5An Experience with Post Covid-19 Rhino-Orbital Cerebral Mucormycosis with Oral Manifestations: A Retrospective Study2024